ReviewFrontiers in cardiovascular medicine2023
Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle.
Review in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 13 citations in OpenAlex.
- Combining MELD-XI score and hemodynamic parameters enhances short-term prognostic value in patients undergoing transcatheter tricuspid valve interventions.Wiener klinische Wochenschrift · 2026Article
- Left Atrial Appendage Thrombus and Dense Spontaneous Echo Contrast in Anticoagulated Atrial Fibrillation Patients Referred for Cardioversion: Beyond CHAJournal of clinical medicine · 2026Article
- When not to reintervene: three-dimensional echocardiography guiding conservative management in frail octogenarian with post-TEER tricuspid regurgitation.Journal of geriatric cardiology : JGC · 2026Article
- Tricuspid Regurgitation-Induced Shunt Reversal Leading to Paradoxical Embolic Stroke.CASE (Philadelphia, Pa.) · 2026Article
- [Spontaneous bacterial peritonitis in cardiac ascites: A case report and review of the literature].Anales del sistema sanitario de Navarra · 2026Review
- Clinical outcomes of tricuspid transcatheter edge-to-edge repair in patients with tricuspid regurgitation.Frontiers in medicine · 2026Article
- The effect of chronic kidney disease on the association of tricuspid regurgitation with overall survival : Insights from SHEBAHEART big data.Journal of nephrology · 2025Article
- C-reactive protein-to-albumin ratio in transcatheter tricuspid valve repair: methodological concerns and ınconsistencies.Clinical research in cardiology : official journal of the German Cardiac Society · 2025Article
- Cine MRI-Derived Radiomics for the Detection of Functional Tricuspid Regurgitation in Pulmonary Hypertension: A Proof-of-Concept Study.Journal of cardiovascular development and disease · 2025Article
- Percutaneous Vegetectomy for Fungal Tricuspid Valve Endocarditis: A Minimally Invasive Approach in A Patient on Veno-Venous ECMO.Cardiovascular and interventional radiology · 2025Article
- C-reactive protein-to-albumin ratio is associated with mortality after transcatheter tricuspid valve repair.Clinical research in cardiology : official journal of the German Cardiac Society · 2025Article
- Point-of-Care Ultrasound in Nephrology: Beyond Kidney Ultrasound.Diagnostics (Basel, Switzerland) · 2025Review
- The right heart perspective in chronic cardiorenal syndrome: the key role of right heart function and tricuspid regurgitation innovation.Frontiers in cardiovascular medicine · 2025Review
- Assessing the correlation between the degree of tricuspid regurgitation and pulmonary hypertension: A comprehensive study.Saudi medical journal · 2024Article
- Giant Right Atrial Myxoma Presenting With Right Heart Failure.Journal of investigative medicine high impact case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a growing interest in the evaluation of tricuspid regurgitation due to its increasing prevalence and detrimental impact on clinical outcomes. Historically, it has been coined the "forgotten" defect in the field of valvular heart disease due to the lack of effective treatments to improve prognosis. However, the development of percutaneous treatment techniques has led to a new era in its management, with promising results and diminished complication risk. In spite of these advances, a comprehensive exploration of the pathophysiological mechanisms is essential to establish clear indications and optimal timing for medical and percutaneous intervention. This review will address the most important aspects related to the diagnosis, pathophysiology and treatment of tricuspid regurgitation from a cardiorenal perspective, with a special emphasis on the interaction between right ventricular dysfunction and the development of hepatorenal congestion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.